The MHRA approves a first-in-class bispecific antibody for HER2-positive biliary tract cancer, offering a new line of therapy for patients who have progressed on standard care.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/her2-therapy-biliary-cancer-approved-uk-regulator-2026a10005eh?src=rss
Author :
Publish date : 2026-02-20 12:11:00
Copyright for syndicated content belongs to the linked Source.
